Hims(US:HIMS) Benzinga·2025-11-26 18:03Core Insights - Whales have shown a bullish sentiment towards Hims & Hers Health, with 44% of trades being bullish and 40% bearish, indicating a strong interest in the stock [1] - The predicted price range for Hims & Hers Health over the last three months has been between $3.0 and $60.0, suggesting significant volatility and potential for price movement [2] - The average open interest for options trades is 1483.33, with a total volume of 6,561.00, reflecting active trading and interest in the stock [3] Options Activity - Noteworthy options activity includes a bullish call trade with a total trade price of $373.9K at a strike price of $3.00, and a bearish put trade with a total trade price of $354.0K at a strike price of $37.00 [7] - The trading volume for Hims & Hers Health stands at 6,413,084, with the stock price increasing by 2.24% to $37.92, indicating positive market sentiment [13] Company Overview - Hims & Hers Health, launched in 2017, is a telehealth platform providing treatment options for various health issues, with over 2 million subscribers and services available in all 50 states and select European markets [8] - The company does not accept insurance, relying on direct payments from customers for its offerings, which include prescription drugs, over-the-counter medicines, and supplements [8] Analyst Ratings - Recent analyst ratings suggest an average target price of $58.5, with one analyst downgrading to a Buy rating with a target of $85, while another maintains an Underperform rating with a target of $32 [10][11]